News

Pharmexa, a biotechnology company, and Affitech AS, a human therapeutic antibody discovery and engineering company, have entered into a conditional agreement to merge the two companies by means

UK-based Stem Cell Sciences has entered into a definitive agreement with StemCells, a US-based biotechnology company, for the sale of the trading subsidiaries of the company and certain

In accordance with Marketplace Rule 4310(c)(8)(C), the company has been provided a period of 90 calendar days, through June 4, 2009, to regain compliance with the Rule. The

Access Pharmaceuticals, a biopharmaceutical company, has announced positive safety and efficacy results from its Phase II monotherapy clinical study of ProLindac in late-stage, heavily pretreated ovarian cancer patients.

Tecan, a supplier of laboratory instruments and solutions, and GE Healthcare, have formed collaboration to bring increased quality and efficiency to process development. The collaboration between the two

Under the terms of the agreement, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough. Each Merck share will automatically become a

The financing will provide the company adequate initial funding to start the roll-out of its thermal imaging systems that detect early signs of pressure ulcers among patients that

The company currently manufactures and markets the oral capsule in China under the Cease Enuresis oral capsule brand, which was approved by China’s State Food and Drug Administration

Prior to joining Enzo Clinical Labs, Dr Krenitsky, who is replacing Shahram Rabbani, was CEO of Bioserve Biotechnologies. Prior to Bioserve, he was CEO of Parkway Clinical Laboratories.